In a 73-year-old hospice patient with end-stage chronic obstructive pulmonary disease and lung cancer who is taking mirtazapine 30 mg nightly and uses lorazepam 0.5 mg as needed up to three times daily, is it reasonable to schedule a nightly lorazepam dose and increase the dose to 1 mg?

Scheduling and Increasing Lorazepam Dose: Not Recommended in This Patient

In this 73-year-old hospice patient with end-stage COPD and lung cancer, scheduling lorazepam 1 mg nightly is not advisable due to the significant respiratory risks associated with benzodiazepines in severe pulmonary insufficiency. The current PRN approach is safer, and alternative medications should be prioritized for scheduled nighttime use.

Critical Safety Concerns with Benzodiazepines in COPD

The most recent ESMO guidelines (2018) explicitly caution against benzodiazepine use in patients with severe pulmonary insufficiency, stating that lower doses (0.25-0.5 mg) should be used in older or frail patients with COPD, particularly when co-administered with other sedating medications 1. Your patient is already receiving mirtazapine 30 mg, which has sedating properties, creating additional risk for oversedation and respiratory depression.

Key respiratory risks include:

• Benzodiazepines reduce respiratory muscle strength by 10-20% and endurance by up to 50% in COPD patients 2
• They cause central respiratory depression with decreased minute ventilation and increased PaCO2 2
• Risk of acute respiratory failure is elevated in older adults with COPD receiving benzodiazepines 3
• The combination of sedating medications (mirtazapine + lorazepam) compounds respiratory depression risk 1

Better Alternatives for Scheduled Nighttime Symptom Management

For Insomnia

The NCCN Palliative Care Guidelines (2016) recommend several safer options for scheduled nighttime use 4:

• Trazodone 25-100 mg PO at bedtime (first-line alternative)
• Olanzapine 2.5-5 mg PO at bedtime (though caution: combining with benzodiazepines risks oversedation)
• Quetiapine 25 mg PO at bedtime (reduced doses in elderly)
• Chlorpromazine 25-50 mg PO at bedtime (for weeks-to-days prognosis)

The patient is already on mirtazapine 30 mg, which is within the recommended range for insomnia (7.5-30 mg) 4. Before adding another agent, assess whether the mirtazapine timing or dose needs optimization.

For Anxiety or Breathlessness

If the PRN lorazepam is being used primarily for anxiety or dyspnea:

• Keep lorazepam PRN at the current 0.5 mg dose rather than scheduling it 1
• The ESMO guidelines specifically recommend 0.25-0.5 mg doses in elderly COPD patients 1
• Consider adding scheduled trazodone or low-dose quetiapine for baseline anxiety management
• For refractory breathlessness, opioids (not benzodiazepines) are the evidence-based first-line treatment 5

Practical Management Algorithm

Step 1: Assess the primary indication for increased nighttime sedation

• If insomnia despite mirtazapine → Add trazodone 25-50 mg at bedtime
• If anxiety → Consider scheduled quetiapine 25 mg at bedtime or optimize daytime anxiety management
• If breathlessness → Ensure adequate opioid dosing; consider low-dose morphine for dyspnea

Step 2: Maintain lorazepam as PRN only

• Keep at 0.5 mg PRN (not 1 mg) given COPD and age 1
• Maximum frequency: 1-3 times daily as currently prescribed
• Use for breakthrough anxiety or acute distress episodes only

Step 3: Monitor for oversedation

• The combination of mirtazapine + any additional sedating agent requires close monitoring
• Watch for increased daytime sedation, confusion, or worsening respiratory status
• FDA labeling warns about respiratory depression risk in COPD patients 6

Critical Pitfalls to Avoid

1. Never schedule benzodiazepines in severe COPD without compelling indication - The respiratory depression risk outweighs benefits for routine insomnia 1, 6

2. Avoid dose escalation to 1 mg in this population - Guidelines consistently recommend 0.25-0.5 mg in elderly COPD patients 1

3. Don't combine multiple sedating agents without careful consideration - The patient already receives mirtazapine; adding scheduled lorazepam creates compounded respiratory risk 1

4. Recognize that benzodiazepines may worsen delirium - If confusion develops, benzodiazepines can paradoxically worsen agitation 1

Special Considerations for Hospice Context

In the hospice setting with weeks-to-days prognosis, the risk-benefit calculation shifts. The 2016 NCCN guidelines acknowledge that for dying patients, chlorpromazine 25-100 mg at bedtime may be appropriate 4. However, even in end-of-life care, the ESMO guidelines emphasize using the lowest effective benzodiazepine doses in COPD patients 1.

If the patient is actively dying and comfort is the sole goal, then scheduled lorazepam becomes more acceptable, but start with 0.5 mg (not 1 mg) and titrate cautiously based on respiratory status and comfort 1, 7.

The evidence strongly supports maintaining the current PRN approach with lorazepam 0.5 mg while adding a safer scheduled agent like trazodone for nighttime symptom management in this patient with severe COPD.